Pre-exposure prophylaxis makes it possible to better live one’s sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about primary motivations for PrEP

Author:

Bistoquet Marie,Makinson Alain,Tribout Vincent,Perrollaz Cyril,Bourrel Gérard,Reynes Jacques,Oude Engberink AgnèsORCID

Abstract

AbstractBackgroundPre-exposure prophylaxis (PrEP) for HIV is instrumental in the prevention of HIV for HIV-uninfected persons, by drastically reducing the risk of acquisition in the case of high-risk exposures. Despite its demonstrated efficacy, it remained under-prescribed in France until 2018. The principal aim of this study was to understand the motivations of Men who have Sex with Men (MSM) who started using PrEP in Montpellier, France.MethodsA phenomenological study was undertaken, using semi-structured interviews with twelve participants attending the University Hospital of Montpellier for PrEP. Interviews were analysed by means of triangulation up to the point of theoretical saturation, using a semio-pragmatic method.ResultsFear of HIV infection, personalised regular follow-up, and the wish to take care of one’s health were the primary motivational factors. PrEP allows for a better sexual life restoring a sense of freedom despite the risks of STI, deemed manageable by PrEPers. PrEP does not modify long-term risk-taking behaviours but helps them better live their own sexuality and guides them towards a responsible approach to sexuality. Unclear information on PrEP, delivered by their family doctor, public campaigns or the media, leads to misrepresentations or negative social representation, including within the MSM community, which may delay its implementation.ConclusionsFear of HIV infection and the benefits of regular medical follow-up to take care of one’s health were motivational factors of importance for the use of PrEP by MSM in this study. PrEP transforms all existential dimensions of their lived experience, improving sexual identity and happiness. There is a need to improve professional awareness of the effectiveness of PrEP and to develop a patient centered approach, to disseminate information more widely to the general public and among MSM to reduce stigmatisation.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Reference43 articles.

1. UNAIDS. Global HIV & AIDS statistics—2020 fact sheet. https://www.unaids.org/fr/resources/fact-sheet. Accessed 14 July 2020.

2. santé publique France. Bulletin de santé publique VIH/SIDA. Octobre 2019 https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/documents/bulletin-national/bulletin-de-sante-publique-vih-sida.-octobre-2019. Accessed 14 July 2020.

3. Florence Lot et Nathalie Lydié. Situation épidémiologique et dépistage du VIH et des autres IST // Epidemiological situation and screening for HIV and other STIs. BEH, santé publique France; 2019. http://beh.santepubliquefrance.fr/beh/2019/31-32/index.html. Accessed 14 July 2020.

4. U.S. Department of Health & Human Services, U.S. Food and Drug Administration. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use. FDA; 2012. https://www.fda.gov/media/83586/download. Accessed 14 July 2020.

5. ANSM : Agence nationale de sécurité du médicament et des produits de santé. La RTU Truvada dans la prophylaxie Pré-Exposition (PrEP) au VIH établie par l’ANSM est effective - Point d’Information—2016. https://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/La-RTU-Truvada-dans-la-prophylaxie-Pre-Exposition-PrEP-au-VIH-etablie-par-l-ANSM-est-effective-Point-d-Information. Accessed 14 July 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3